Leleu-ecancer Web
Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France
30 Sep 2020
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma
Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain
25 Sep 2020
Managing multiple myeloma in a COVID-19 world
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
25 Sep 2020
OncoAlert and ecancer weekly roundup for September 6-13, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
14 Sep 2020
Total body radiation vs chemotherapy-based conditioning in children and adolesce...
Prof Christina Peters - Children's Cancer Research Institute, Vienna, Austria
9 Sep 2020
Using the Viber app for managing haematological malignancies from home
Dr Bishesh Poudyal - Civil Service Hospital Nepal, Kathmandu, Nepal
1 Sep 2020
The impact of COVID-19 on ALL patients in Spain
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
22 Jul 2020
How should we manage patients with acute lymphoblastic leukaemia during COVID-19...
Dr Christopher Benton - Rocky Mountain Cancer Centers, Denver, USA
20 Jul 2020
Evaluating the impact of daratumumab for the treatment of multiple myeloma accor...
Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA
10 Jul 2020
MASTER trial updates: Dara-KRd induction, autologous transplantation and MRD res...
Dr Luciano Costa - O'Neal Comprehensive Cancer Center at UAB, Birmingham, USA
9 Jul 2020
UKALL2011: Treatment with a tyrosine kinase inhibitor improves outcomes for pati...
Prof Anthony Moorman - Newcastle University, Newcastle upon Tyne, UK
9 Jul 2020
Long-term disease control in multiple myeloma by in-class transitioning: A commu...
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
3 Jul 2020
